======= HESX1 ======= == Gene Information == * **Official Symbol**: HESX1 * **Official Name**: HESX homeobox 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8820|8820]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UBX0|Q9UBX0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HESX1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HESX1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601802|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a conserved homeobox protein that is a transcriptional repressor in the developing forebrain and pituitary gland. Mutations in this gene are associated with septooptic dysplasia, HESX1-related growth hormone deficiency, and combined pituitary hormone deficiency. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Required for the normal development of the forebrain, eyes and other anterior structures such as the olfactory placodes and pituitary gland. Possible transcriptional repressor. Binds to the palindromic PIII sequence, 5'-AGCTTGAGTCTAATTGAATTAACTGTAC-3'. HESX1 and PROP1 bind as heterodimers on this palindromic site, and, in vitro, HESX1 can antagonize PROP1 activation. {ECO:0000250|UniProtKB:Q61658, ECO:0000269|PubMed:26781211}. |Homeobox| |otic vesicle formation| |otic vesicle morphogenesis| |forebrain morphogenesis| |otic vesicle development| |nose development| |brain morphogenesis| |pituitary gland development| |diencephalon development| |inner ear morphogenesis| |protein N-terminus binding| |ear morphogenesis| |endocrine system development| |epithelial tube formation| |tube formation| |protein C-terminus binding| |inner ear development| |respiratory system development| |ear development| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |sensory organ morphogenesis| |embryonic organ morphogenesis| |epithelial tube morphogenesis| |forebrain development| |chromatin binding| |gland development| |morphogenesis of an epithelium| |embryonic organ development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |sensory organ development| |tissue morphogenesis| |embryonic morphogenesis| |tube morphogenesis| |brain development| |head development| |tube development| |negative regulation of transcription by RNA polymerase II| |anatomical structure formation involved in morphogenesis| |animal organ morphogenesis| |embryo development| |central nervous system development| |epithelium development| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of gene expression| |tissue development| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16264 * **Expression level (log2 read counts)**: 0.61 {{:chemogenomics:nalm6 dist.png?nolink |}}